BP

Bhikhabhai Patel Dahyalal

Director Director DIN 07709698
DIN 07709698 First appointment Feb 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhikhabhai Patel Dahyalal

Data last updated:

Bhikhabhai Patel Dahyalal was a Director at Ryzer Pharmaceutical Private Limited (2018–2024) and Director at Accupharm Pharmaceuticals Private Limited (from 2017). The companies operate in Pharma.

DIN 07709698
Primary Designation Director
Industry Pharma
First Appointment 01 Feb 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ryzer Pharmaceutical Private Limited U74999GJ2018PTC104523
Director01 Oct 20182018₹7.71 Cr (FY 2025)Active
Director01 Feb 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Accupharm Pharmaceuticals Private Limited
Ryzer Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Bhikhabhai Patel Dahyalal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhikhabhai Patel Dahyalal

Bhikhabhai Patel Dahyalal was first appointed on 01 Feb 2017 as Director at Accupharm Pharmaceuticals Private Limited. The most recent appointment on record is 01 Oct 2018 at Ryzer Pharmaceutical Private Limited.

Bhikhabhai Patel Dahyalal held 2 earlier board appointments: Ryzer Pharmaceutical Private Limited (Director, 01 Oct 2018 to 26 Mar 2024); Accupharm Pharmaceuticals Private Limited (Director, from 01 Feb 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available